**About Human Pharmaceutical Business**

With global presence, Boehringer Ingelheim has industry-leading expertise in medicine research and development. We are constantly developing the next generation of medical breakthroughs and successfully delivering innovations to meet the medical needs of the patients we serve in the following key areas of interest: cardiovascular, respiratory, metabolic diseases, immunology, oncology and central nervous system. In the future, we will accelerate the launch of more than 10 innovative medicines to meet the demand of Chinese patients.

**Responsibilities**

+ Contribute China CMC regulatory strategy and manage regulatory CMC risks across development and lifecycle stages
+ Review China specific CMC dossiers ensuring compliance with China regulatory requirements
+ Support CMC responses to authority questions and deficiency letters
+ Support with China Health Authorities (e.g. IDC) and support regulatory interactions su...